Effect of Phenobarbital Neonatal Ichter
Not Applicable
- Conditions
- eonatal jaundice.Neonatal jaundice, unspecified
- Registration Number
- IRCT20170215032587N2
- Lead Sponsor
- Ghoum University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 142
Inclusion Criteria
Have a major risk factors for development of severe hyperbilirubinemia
Hospitalized because of hyperbilirubinemia in the first 10 days of birth
Exclusion Criteria
Major congenital malformations
Gestational age <35 weeks
Weight <2500 g at birth
History of blood transfusion
History of IVIG administration
History of maternal use of phenobarbital in the last month of pregnancy
Whose parents refused to give consent
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of readmissions for neonatal jaundice. Timepoint: 7 days after discharge. Method of measurement: Physician examination.
- Secondary Outcome Measures
Name Time Method Mean serum bilirubin levels. Timepoint: Before intervention and 1, 3, 5, 7 day after intervention. Method of measurement: Blood test.;Adverse effects of phenobarbital (feed intolerance, lethargy, apnea and cyanotic spells). Timepoint: During 1 weeks after intervention. Method of measurement: Physician examination.